Expert Video - What happens after a melanoma clinical trial is completed?
Melanoma experts Dr. Sapna Patel and Dr. Michael B. Atkins discuss what happens after a melanoma clinical trial is completed. Dr. Patel also discusses considerations for when a participant can stay on clinical trial treatment and what happens if the FDA approves a clinical trial treatment for melanoma. In addition, Dr. Akins discusses successful immunotherapy clinical trials for melanoma and data safety monitoring of melanoma clinical trials.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about melanoma which will help other patients, caregivers and families.
This educational activity has been developed by the Melanoma Research Foundation (MRF), and Mechanisms in Medicine Inc.
This activity is supported by independent educational grants from Bristol-Myers Squibb, Foundation Medicine, Genentech, Iovance Biotherapeutics, Merck, Natera, and Novartis.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.